Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

New compounds from Senju under evaluation for complications of diabetes

July 5, 1999

Thienopyrimidine inhibitors of PDE5 described by Merck KGaA

July 5, 1999

Novo Nordisk seeks approval for liquid GH in the U.S.

July 5, 1999

Amylin initiates phase II study of AC-2993 in type II diabetes

July 5, 1999

TAP Holdings seeks approval of erectile dysfunction treatment

July 2, 1999

Teijin patents new vitamin D3 derivatives

July 2, 1999

Inhale begins patient dosing in phase III trial for inhaled insulin

July 2, 1999

FDA reduces warnings on Preven emergency contraceptive kit

July 2, 1999

OP-1 Implant filed for approval on two continents for orthopedic indication

July 1, 1999

Australian team presents in vivo results with new, orally active C5a receptor antagonist

June 30, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 1, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Breakthrough as GSK’s bepirovirsen clears 19% of chronic hep B infections
BioWorld
GSK plc has announced a breakthrough in the treatment of chronic hepatitis B, reporting a functional cure rate of 19% across two phase III trials of its antisense...
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...